feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Amanita Muscaria: Deadly Fad Masquerading as Health Aid

Amanita Muscaria: Deadly Fad Masquerading as Health Aid

27 Jan

•

Summary

  • Amanita muscaria, or fly agaric, is widely sold despite its toxicity.
  • Unregulated products often contain undisclosed psychoactive ingredients.
  • Misleading health claims fuel dangerous consumption of toxic mushrooms.
Amanita Muscaria: Deadly Fad Masquerading as Health Aid

Psychedelic drugs are undergoing serious medical research, with psilocybin showing promise for severe depression and awaiting potential FDA approval. However, this interest has unfortunately fueled the market for more dangerous hallucinogenic mushrooms like amanita muscaria, commonly known as fly agaric. Despite its known harms and lack of medical proof, amanita muscaria products are openly sold due to a regulatory gap.

Unlike psilocybin, amanita muscaria and its compounds are not federally controlled. This has allowed vape shops and online retailers to distribute harvested mushrooms and muscimol-derived products, often with unsubstantiated health claims. A 2024 study revealed a 114 percent increase in Google searches for these mushrooms, and a Rand report estimated 3.5 million American adults used them in 2025.

Experts believe consumers are confusing amanita with psilocybin, amplified by aggressive marketing. This misinformation has led to tragic outcomes, including a 2024 outbreak linked to 180 illnesses, 73 hospitalizations, and three deaths across 34 states. Testing revealed products contained psilocybin and prescription drugs, with arbitrary dosages and undisclosed ingredients.

Furthermore, amanita products are often packaged as appealing gummies and chocolates, resembling children's treats, with minimal warning labels. This poses a significant risk to children, who are more susceptible to toxic effects. While the FDA has issued warnings, federal enforcement has been limited, leaving states to implement consumer protections such as age restrictions and mandatory testing.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Amanita muscaria, or fly agaric, is a toxic mushroom sold in unregulated products with baseless health claims, leading to confusion and harm.
Unregulated products often contain undisclosed psychoactive ingredients and prescription drugs, with arbitrary dosages, posing significant health risks.
The FDA has issued warnings, but federal enforcement is limited, prompting calls for states to implement consumer protections and public education.

Read more news on

Healthside-arrow
trending

Ohio snow emergency declared

trending

TikTok down in United States

trending

Andreeva matches Venus Williams' feat

trending

Warrington Hospital baby death

trending

Alexander Zverev advances in Australia

trending

Oilers host Capitals

trending

London celebrates Chinese New Year

trending

Liza Minnelli defends AI use

You may also like

Obesity Pill: Cheaper, Needle-Free Future for UK?

15 Jan • 80 reads

article image

Addiction Warning For Common Pain, Anxiety Meds

12 Jan • 62 reads

article image

Xeris Stock Soars on Rival Drug Rejection

2 Jan • 129 reads

article image

Oregon's Psychedelic Dream Fades: High Costs, Low Diversity

12 Dec, 2025 • 130 reads

article image

FDA Proposes Catch-Up for US Sunscreen Standards

12 Dec, 2025 • 222 reads

article image